U.S. should merge anemia drug, dialysis costs, report says


Reuters - Medicare, the U.S. insurance program
for elderly and disabled Americans, should lump the price of
anemia drugs with overall payments for kidney dialysis services
to improve efficiency and contain costs, according to a
government report released on Tuesday.